Acute Porphyria Drug Database

Monograph

V08CA01 - Gadopentetic Acid
Not porphyrinogenic
NP

Rationale
Gadopentetic acid is not metabolized, it is excreted unchanged through the kidneys.
Chemical description
Gadopentetic acid is an ionic gadolinium chelate.
Therapeutic characteristics
Gadopentetic acid is used as a contrast medium in magnetic resonance imaging. It is given intravenously, by intra-articular injection, orally or rectally.
Hepatic exposure
Not significant
Metabolism and pharmacokinetics
Gadopentetic acid is not metabolized, it is excreted unchanged through the kidneys.
Similar drugs
Explore alternative drugs in similar therapeutic classes V08C / V08CA or go back.

References

# Citation details PMID
*Drug reference publications
1. Sweetman SC, editor. Martindale: The complete drug reference. Gadopentetic acid. Pharmaceutical Press 2009.
*Summary of Product Characteristics
2. Norwegian medicines agency. Summary of Product Characteristics (SPC). Magnevist.

Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Magnevist Magnevist Magnevist
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙